Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center recalls PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chloride Injection-250 mL Total Dose: (500 mcg/
Recalled October 30, 2019 · FDA recall D-0147-2020 · Nephron Pharmaceuticals Corporation
Hazard
GMP Deviations: potential glass contamination · FDA Class II
Units
1855 bags
Sold at
Nationwide.
Description
GMP Deviations: potential glass contamination
Product
PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chloride Injection-250 mL Total Dose: (500 mcg/156.3 mg)/250 mL, Rx Only, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC 69374-0525-25
Manufacturer(s)
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →